Cargando…

Progress toward improving outcomes in patients with cholangiocarcinoma

PURPOSE OF REVIEW: To provide an update on latest advances in treatment of cholangiocarcinoma. RECENT FINDINGS: Incidence of cholangiocarcinoma has been increasing over the past decade. A better understanding of the genetic landscape of cholangiocarcinoma and its risk factors resulted in earlier dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawasaki, Hiroko, Akazawa, Yuko, Razumilava, Nataliya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054970/ https://www.ncbi.nlm.nih.gov/pubmed/33883870 http://dx.doi.org/10.1007/s11938-021-00333-2

Ejemplares similares

Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27
por: Ding, Xiwei, et al.
Publicado: (2022)

Urinary phosphorus excretion per creatinine clearance as a prognostic marker for progression of chronic kidney disease: a retrospective cohort study
por: Kawasaki, Tomoki, et al.
Publicado: (2015)

Progress in Radiotherapy for Cholangiocarcinoma
por: Wang, Ningyu, et al.
Publicado: (2022)

Indian Hedgehog Suppresses Intestinal Inflammation
por: Razumilava, Nataliya, et al.
Publicado: (2017)

Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation()
por: Hibdon, Elise S., et al.
Publicado: (2019)

Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma
por: Sio, Terence T., et al.
Publicado: (2016)

Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis
por: Phanthaphol, Nattaporn, et al.
Publicado: (2017)

The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression
por: Mancarella, Serena, et al.
Publicado: (2022)

Anticancer Activity of (±)-Kusunokinin Derivatives towards Cholangiocarcinoma Cells
por: Rattanaburee, Thidarath, et al.
Publicado: (2022)

CyberKnife Stereotactic Radiosurgery for Cholangiocarcinoma
por: Harada, Yuko, et al.
Publicado: (2017)

Silibinin Therapy Improves Cholangiocarcinoma Outcomes by Regulating ERK/Mitochondrial Pathway
por: Bai, Yang, et al.
Publicado: (2022)

Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma
por: Saboo, Sachin S., et al.
Publicado: (2011)

Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress
por: Gadaleta-Caldarola, Gennaro, et al.
Publicado: (2022)

Role of mTOR inhibitor in cholangiocarcinoma cell progression
por: MOOLTHIYA, PENPAK, et al.
Publicado: (2014)

Characteristic Analysis of Featured Genes Associated with Cholangiocarcinoma Progression
por: Yao, Qigu, et al.
Publicado: (2023)

Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
por: Ruiz de Gauna, Mikel, et al.
Publicado: (2022)

High BLM Expression Predicts Poor Clinical Outcome and Contributes to Malignant Progression in Human Cholangiocarcinoma
por: Du, Xiaolong, et al.
Publicado: (2021)

Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis
por: Ma, Ka Wing, et al.
Publicado: (2019)

Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma
por: Fostea, Raluca Maria, et al.
Publicado: (2020)

Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms
por: Roy, Sukanya, et al.
Publicado: (2019)

Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular–cholangiocarcinoma
por: Chiu, Tai-Jan, et al.
Publicado: (2020)

Nationwide treatment and outcomes of perihilar cholangiocarcinoma
por: van Keulen, Anne‐Marleen, et al.
Publicado: (2021)

Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver
por: Wang, Jue, et al.
Publicado: (2010)

Predictive Factors of Early Recurrence in Patients with Distal Cholangiocarcinoma after Pancreaticoduodenectomy
por: Ito, Yasuhiro, et al.
Publicado: (2018)

FOXK1 plays an oncogenic role in the progression of hilar cholangiocarcinoma
por: Feng, Yujie, et al.
Publicado: (2021)

Downregulation of MCM8 expression restrains the malignant progression of cholangiocarcinoma
por: Hao, Jingcheng, et al.
Publicado: (2021)

Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma
por: DHANASEKARAN, RENUMATHY, et al.
Publicado: (2013)

Characteristics and clinical outcomes in young‐onset cholangiocarcinoma
por: Reddy, Sarah, et al.
Publicado: (2023)

The Application Progress of Patient-Derived Tumor Xenograft Models After Cholangiocarcinoma Surgeries
por: Wu, Jun, et al.
Publicado: (2021)

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
por: Cheng, Chi-Tung, et al.
Publicado: (2015)

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials
por: Ledenko, Matthew, et al.
Publicado: (2022)

C‐X‐C motif chemokine ligand 1 induced by Hedgehog signaling promotes mouse extrahepatic bile duct repair after acute injury
por: Mohamad Zaki, Nureen H., et al.
Publicado: (2022)

Active Autophagy Is Associated with Favorable Outcome in Patients with Surgically Resected Cholangiocarcinoma
por: Bankov, Katrin, et al.
Publicado: (2023)

Diagnosis of Distal Cholangiocarcinoma after the Removal of Choledocholithiasis
por: Ito, Yasuhiro, et al.
Publicado: (2012)

Cholangiocarcinoma in a Child with Progressive Abdominal Distension and Secondary Hypercalcemia
por: Monsereenusorn, Chalinee, et al.
Publicado: (2018)

Periostin and mesothelin: Potential predictors of malignant progression in intrahepatic cholangiocarcinoma
por: Mandrekar, Pranoti, et al.
Publicado: (2018)

DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives
por: Gönül Geyik, Öykü, et al.
Publicado: (2022)

PRDX6 knockout restrains the malignant progression of intrahepatic cholangiocarcinoma
por: Li, Hong, et al.
Publicado: (2022)

Multiparametric Magnetic Resonance Imaging Improves the Prognostic Outcomes in Patients With Intrahepatic Cholangiocarcinoma After Curative-Intent Resection
por: Li, Qian, et al.
Publicado: (2022)

Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology
por: Capuozzo, Maurizio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k1k1finfd6o228e8s76cuei8dp